Skip to main content
. 2018 Jan 1;9(3):502–511. doi: 10.7150/jca.22163

Figure 1.

Figure 1

Synthesis and characterization of Abra/anti-HER2 (A)Schematic diagram of the synthesis of Abra/anti-HER2 nanoparticles (The -COOH of Abraxane® and -NH2 of anti-HER2 antibody were combined by a “one-step” method using EDC/NHS to form a stable -CO-NH- linker) (B) Transmission electron microscopic images of Abraxane®(left) and Abra/anti-HER2(right) (C) Particle size distribution of Abra/anti-HER2.